UC San Francisco Law Professor Dorit Reiss and attorney Richard Hughes of Epstein Becker Green sat down with GRIP’s US Content Manager Julie DiMauro to discuss US vaccine policy shifts, including FDA limits on COVID-19 shots, expanded legal challenges, and political interference under new leadership at HHS.
They discussed:
- manufacturer risk and labeling uncertainties;
- the consequences of misinformation;
- litigation challenging new federal health policy and grant cancellations;
- limits on the ability to sue in torts, possible, other legal remedies;
- how the new HHS policies on vaccines affect technical expertise, quality control, and highly specialized supply chains; and
- the effects of tariffs, research funding cuts, and slower reviews on pharmaceutical companies.
A transcript of the podcast is available here.